Identifying and managing sources of pain and distress in children with neurological impairment

Pediatric Annals

Volumn 39, Issue 4, 2010, Pages 198-205

  Hauer, Julie ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BACLOFEN; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CARBAMAZEPINE; CLONIDINE; CODEINE; CYPROHEPTADINE; DANTROLENE; DIAZEPAM; DICYCLOVERINE; ENEMA; FENTANYL; GABAPENTIN; HYDROMORPHONE; LACTULOSE; LAMOTRIGINE; MACROGOL 3350; MORPHINE; MORPHINE SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OXYCODONE; PARACETAMOL; PROTON PUMP INHIBITOR; TIZANIDINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ACUPUNCTURE; ANTICHOLINERGIC EFFECT; AROMATHERAPY; AUTONOMIC DYSFUNCTION; BEDTIME DOSAGE; CHILD; CONSTIPATION; DISEASE SEVERITY; DROWSINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MECHANISM; DYSAUTONOMIA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL PAIN; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABILITY; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NOCICEPTION; PAIN; PAIN ASSESSMENT; PHYSIOTHERAPY; PRESCHOOL CHILD; RATING SCALE; RELAXATION TRAINING; RETCHING; REVIEW; SCHOOL CHILD; SEDATION; SELF REPORT; SIDE EFFECT; SPASTICITY; THALAMIC PAIN SYNDROME; TRANSCUTANEOUS NERVE STIMULATION; UNSPECIFIED SIDE EFFECT; VISCERAL PAIN; VOMITING;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANALGESICS; CALCIUM CHANNEL BLOCKERS; CHILD; DISABLED CHILDREN; HUMANS; HYPERALGESIA; NERVOUS SYSTEM DISEASES; PAIN; PAIN MEASUREMENT; SEROTONIN ANTAGONISTS;

EID: 77951558515     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20100318-04     Document Type: Review

References (39)

1. Breau LM, Camfield CS, McGrath PJ, Finley GA. The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med. 2003;157(12):1219-1226.
2. Stallard P, Williams L, Lenton S, Velleman R. Pain in cognitively impaired, noncommunicating children. Arch Dis Child. 2001;85(6):460-462.
3. Houlihan CM, O'Donnell M, Conaway M, Stevenson RD. Bodily pain and health-related quality of life in children with cerebral palsy. Dev Med Child Neurol. 2004;46(5):305-310.
4. Hunt A, Goldman A, Seers K, et al. Clinical validation of the paediatric pain profile. Dev Med Child Neurol. 2004;46(1):9-18.
5. Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, et al. Pain in children and adolescents: a common experience. Pain. 2000;87(1):51-58.
6. Breau LM, Camfield C, McGrath PJ, Rosmus C, Finley GA. Measuring pain accurately in children with cognitive impairments: refinement of a caregiver scale. J Pediatr. 2001;138(5):721-727.
7. Hunt A, Wisbeach A, Seers K, Goldman A, Crichton N, Perry L, Mastroyannopoulou K. Development of the paediatric pain profile: role of video analysis and saliva cortisol in validating a tool to assess pain in children with severe neurological disability. J Pain Symptom Manage. 2007;33(3):276-289.
8. Breau LM, McGrath PJ, Camfield C, Rosmus C, Finley GA. Preliminary validation of an observational pain checklist for persons with cognitive impairments and inability to communicate verbally. Dev Med Child Neurol. 2000;42(9):609-616.
9. Stallard P, Williams L, Velleman R, Lenton S, McGrath PJ. Brief report: behaviors identified by caregivers to detect pain in noncommunicating children. J Pediatr Psychol. 2002;27(2):209-214.
10. Malviya S, Voepel-Lewis T, Burke C, Merkel S, Tait AR. The revised FLACC observational pain tool: improved reliability and validity for pain assessment in children with cognitive impairment. Paediatr Anaesth. 2006;16(3):258-265.
11. Breau LM, McGrath PJ, Camfield CS, Finley GA. Psychometric properties of the non-communicating children's pain checklist-revised. Pain. 2002;99(1-2):349-357.
12. Hauer JM. Central hypothermia as a cause of acute pancreatitis in children with neurodevelopmental impairment. Dev Med Child Neurol. 2008;50(1):68-70.
13. Berde CB, Lebel AA, Olsson G. Neuropathic Pain in Children. In: Schechter NL, Berde CB, Yaster M (Eds). Pain in Infants, Children, and Adolescents. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2003:620-641.
14. Greco C, Berde C. Pain management for the hospitalized pediatric patient. Pediatr Clin North Am. 2005;52(4):995-1027, vii-viii.
15. Oberlander TR, Craig KD. Pain and Children with Developmental Disabilities. In: Schechter NL, Berde CB, Yaster M (Eds). Pain in Infants, Children, and Adolescents. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins;2003:599-619.
16. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618-1625.
17. Lauder GR, White MC. Neuropathic pain following multilevel surgery in children with cerebral palsy: a case series and review. Paediatr Anaesth. 2005;15(5):412-420.
18. Delgado-Aros S, Camilleri M. Visceral hypersensitivity. J Clin Gastroenterol. 2005;39(5 Suppl 3):S194-203; discussion S210.
19. Carter B, McArthur E, Cunliffe M. Dealing with uncertainty: parental assessment of pain in their children with profound special needs. J Adv Nurs. 2002;38(5):449-457.
20. Zangen T, Ciarla C, Zangen S, et al. Gastro-intestinal motility and sensory abnormalities may contribute to food refusal in medically fragile toddlers..J Pediatr Gastroenterol Nutr. 2003;37(3):287-293.
21. Hauer JM, Wical BS, Charnas L. Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment. Pediatrics. 2007;119(2):e519-e522.
22. Nicholson BD. Evaluation and treatment of central pain syndromes. Neurology. 2004;62(5 Suppl 2):S30-6.
23. Frese A, Husstedt IW, Ringelstein EB, Evers S. Pharmacologic treatment of central post-stroke pain. Clin J Pain. 2006;22(3):252-260.
24. Krach LE. Pharmacotherapy of spasticity: oral medications and intrathecal baclofen. J Child Neurol. 2001;16(1):31-36.
25. Montané E, Vallano A, Laporte JR. Oral anti-spastic drugs in nonprogressive neurologic diseases: a systematic review. Neurology. 2004;63(8):1357-1363.
26. Bes A, Eyssette M, Pierrot-Deseilligny E, Rohmer F, Warter JM. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia. Curr Med Res Opin. 1988;10(10):709-718.
27. Medici M, Pebet M, Ciblis D. A double-blind, long-term study of tizanidine ('Sirdalud') in spasticity due to cerebrovascular lesions. Curr Med Res Opin. 1989;11(6):398-407.
28. Cutter NC, Scott DD, Johnson JC, Whiteneck G. Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial. Arch Phys Med Rehabil. 2000;81(2):164-169.
29. Williams DG, Patel A, Howard RF. Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth. 2002;89(6):839-845.
30. Ciszkowski C, Madadi P, Phillips MS, Lauwers AE, Koren G. Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med. 2009;361(8):827-828.
31. Gardner JS, Blough D, Drinkard CR, et al. Tramadol and seizures: a surveillance study in a managed care population. Pharmacotherapy. 2000;20(12):1423-1431.
32. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.
33. Korn-Merker E, Borusiak P, Boenigk HE. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety. Epilepsy Res. 2000;38(1):27-32.
34. Haig GM, Bockbrader HN, Wesche DL, Boellner SW, Ouellet D, Brown RR, Randinitis EJ, Posvar EL. Single-dose gabapentin pharmacokinetics and safety in healthy infants and children. J Clin Pharmacol. 2001;41(5):507-514.
35. Kloos RT. Spontaneous periodic hypothermia. Medicine (Baltimore). 1995;74(5):268-280.
36. Baguley IJ, Heriseanu RE, Gurka JA, Nordenbo A, Cameron ID. Gabapentin in the management of dysautonomia following severe traumatic brain injury: a case series. J Neurol Neurosurg Psychiatry. 2007;78(5):539-541.
37. Axelrod FB, Berlin D. Pregabalin: a new approach to treatment of the dysautonomic crisis. Pediatrics. 2009;124(2):743-746.
38. Richards CA, Milla PJ, Andrews PL, Spitz L. Retching and vomiting in neurologically impaired children after fundoplication: predictive preoperative factors. J Pediatr Surg. 2001;36(9):1401-1404.
39. Antao B, Ooi K, Ade-Ajayi N, Stevens B, Spitz L. Effectiveness of alimemazine in controlling retching after Nissen fundoplication. J Pediatr Surg. 2005;40(11):1737-1740.